This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Pharmacists can also provide diabetes management as an embedded member of clinic or hospital locations. May 15, 2024. Kirsty [package insert]. According to an article in Diabetes, Metabolic Syndrome and Obesity , the authors acknowledge how the role of the pharmacist has changed over the last 50 years. News release.
Innovator oligonucleotide-based drugs targeting central nervous system (CNS) indications witnessed a 339% ($2.17bn) increase in total licensing agreement deal value from 2023 to 2024, reaching a total deal value of $2.81bn, according to GlobalData’s Pharma Intelligence Center Deals Database.
EU’s Pharma Package falls short of Europe’s goal of global competitiveness Why can’t the US figure out weight loss drug prices? Find out more Introduced by the Medicines and Healthcare products Regulatory Agency (MHRA), it will allow patients to receive personalised treatments made at their hospital, clinic or near their homes.
On average, 58% of branded drugs approved between 2021 and 2024 in Europe have either fully or restricted reimbursement. First, the access landscape for 220 originator medicines approved by the EMA between 2021–2024 was assessed. Reimbursement status for each brand per European market was analysed during this period.
2024 ESC guidelines for the management of elevated blood pressure and hypertension. doi:10.1016/20S0140-6736(22)02034-7 Aprocitentan (Tryvio) package insert. Widaplik (telmisartan, amlodipine, indapamide) package insert. Jansen, PharmD Candidate , Mark A. J Am Coll Cardiol. 2018;71:e127-e248. doi:10.1016/j.jacc.2017.11.006
The National Child Mortality Database report on child deaths related to asthma and allergies was released in December 2024, providing sobering insights. Key findings in this review emphasised that most of these children and young people died before reaching the hospital, with 46% receiving inadequate asthma care. Accessed March 2025].
The financial conditions outlined in the extended agreement covering the three new ADC projects remain consistent with those specified in the original agreement signed in January 2024 for the initial three projects. In September 2024, Orion entered a partnership with Aitia to leverage AI in drug discovery and simulation in the oncology field.
Experts praise the reforms to rare disease and antimicrobial research, but they worry that some provisions in the EU Pharma Package may harm innovation on the continent, contrary to its stated objectives. In a bid to chase competitiveness, the EU is advancing its most drastic revision of pharmaceutical law in 20 years.
EU’s Pharma Package falls short of Europe’s goal of global competitiveness Why can’t the US figure out weight loss drug prices? Give your business an edge with our leading industry insights. Give your business an edge with our leading industry insights.
EU’s Pharma Package falls short of Europe’s goal of global competitiveness Why can’t the US figure out weight loss drug prices? Give your business an edge with our leading industry insights. Give your business an edge with our leading industry insights.
From the Dilantin package insert: “The free acid form of phenytoin is used in DILANTIN-125 Suspension and DILANTIN Infatabs. Pharmaceutical Technology Trends in Manufacturing eBook May 2024. Selecting of the appropriate pharmaceutical alternative requires technical judgment. Mancini, A. Thakar, N. and Chaiyaperm, V.
In 2024, Otsuka announced the acquisition of US-based Jnana Therapeutics in a deal worth up to $1.1bn. Cell & Gene Therapy coverage on Pharmaceutical Technology is supported by Cytiva. Give your business an edge with our leading industry insights. Give your business an edge with our leading industry insights.
Detect-A-Dose lid-label cover enhances medication recognition, reducing packaging errors through a contrasting visual pattern. Concerningly, preventable adverse events due to medication errors cause an estimated 44,000 to 98,000 hospital deaths annually, more than the number attributed to motor vehicle accidents.
Only 4% of global drugs sales will have patent protection, compared to 12% and 6% in 2022 and 2024. Keytruda, approved to treat a range of solid tumours, was the top selling drug in the world in 2024, netting over $29bn in annual sales. How will RFK Jr’s American dream for vaccines play out?
EU’s Pharma Package falls short of Europe’s goal of global competitiveness Why can’t the US figure out weight loss drug prices? The investment represents a substantial capital infusion to the $3.5bn announced in November 2024. Give your business an edge with our leading industry insights.
EU’s Pharma Package falls short of Europe’s goal of global competitiveness Why can’t the US figure out weight loss drug prices? Give your business an edge with our leading industry insights. Give your business an edge with our leading industry insights.
In June 2024, the company opened a new facility at the same site, which has already begun producing high-quality prefillable glass syringes. By GlobalData Learn more about Strategic Intelligence SCHOTT Pharma CEO Andreas Reisse stated: “To meet growing demand, we are expanding our capabilities and presence in the diabetes and obesity fields.
EU’s Pharma Package falls short of Europe’s goal of global competitiveness Why can’t the US figure out weight loss drug prices? Give your business an edge with our leading industry insights. Give your business an edge with our leading industry insights.
EU’s Pharma Package falls short of Europe’s goal of global competitiveness Why can’t the US figure out weight loss drug prices? Give your business an edge with our leading industry insights. Give your business an edge with our leading industry insights.
In 2024, an estimated 40.8 In June 2025, the White House submitted a formal rescissions package to Congress that proposed eliminating billions in foreign aid funding—including over $8 billion allocated to USAID. SHOW MORE Pharmacists play a vital role in translating global health news into actionable knowledge for their communities.
. | Image Credit: REDPIXEL - stock.adobe.com Thimerosal is a mercury-containing compound that has been widely used as a preservative in some biological and drug products, such as promoting the safe use of multidose vials and packaging of vaccines. receiving the recommended 2024-2025 COVID-19 vaccine. 4 REFERENCES 1.
The spray’s UK approval follows its launch in Spain in 2024 and in Germany last month. How will RFK Jr’s American dream for vaccines play out? ALK signed an agreement with ARS for the exclusive licensing and commercialisation rights to EURneffy in the UK and EU last year. Don’t let policy changes catch you off guard.
Anticipated next steps involve generating preclinical candidate data packages, which will include non-human primate studies expected in early 2026. How will RFK Jr’s American dream for vaccines play out? Following these outcomes, Acumen holds exclusive rights to develop up to two development candidates.
Madrigal accessed a large US market when it won accelerated US Food and Drug Administration (FDA) approval in March 2024 for the first MASH treatment in the region. in 2024, with $103.3m If approved in Europe, Rezdiffra would have the same indication. Don’t let policy changes catch you off guard. of that coming in Q4 alone.
Indeed the $9.5bn in sales it generated in 2024, which includes revenue from a high-dose version, means it is one of the top-selling drugs in the world. Eylea’s glory days ending Alvotech is just the latest pharma company to spur an Eylea biosimilar into the European market after Bayer’s blockbuster lost regulatory exclusivity in mid-2024.
How will RFK Jr’s American dream for vaccines play out? Give your business an edge with our leading industry insights. Give your business an edge with our leading industry insights.
30, 2024 , TIRF manufacturers stopped production of these forms of medications. DEA, 2024) Fentanyl currently comes as an intravenous (IV) injection and a topical patch. Fentanyl lozenges, lollipops, sublingual tablets, and nasal sprays are no longer produced as of September 30, 2024. DEA, 2024) Another report found that U.S.
We organize all of the trending information in your field so you don't have to. Join 5,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content